Health Care & Life Sciences » Pharmaceuticals | Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.3
Market Cap
$99.13 M
Shares Outstanding
15.54 M
Public Float
8.96 M

Profile

Address
2525 West End Avenue
Nashville Tennessee 37203
United States
Employees -
Website http://www.cumberlandpharma.com
Updated 07/08/2019
Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A.

Financials

View All

A. J. Kazimi
Chairman & Chief Executive Officer
Martin E. Cearnal
Director, Executive VP-Marketing & Sales